α-Tocopherol (phosphate) [38976-17-9]
Cat# HY-16686-5mg
Size : 5mg
Brand : MedChemExpress
| Description | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| In Vitro |
α-Tocopherol phosphate (100 μM, 24 h) inhibits high Glucose (HY-B0389)/ischemic-induced apoptosis and migration in endothelial progenitor cells, promotes capillary-like tube formation through regulation of Bcl-2, Akt, NF-κB, p38MAPK and JNK expressions[2]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot Analysis[2]
Cell Migration Assay [2]
|
||||||||||||||||
| In Vivo |
α-Tocopherol phosphate (100 μM, intramuscular, single dose) exhibits angiogenesis-promoting activity in Streptozotocin (HY-13753) and ligation induced rats type 2 diabetes and ischemia models[2]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
|
||||||||||||||||
| Molecular Weight |
510.69 |
||||||||||||||||
| Formula |
C29H51O5P |
||||||||||||||||
| CAS No. | |||||||||||||||||
| Appearance |
Solid |
||||||||||||||||
| Color |
White to off-white |
||||||||||||||||
| SMILES |
CC1=C(O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CC2)C2=C(C)C(OP(O)(O)=O)=C1C |
||||||||||||||||
| Shipping | Room temperature in continental US; may vary elsewhere. |
||||||||||||||||
| Storage |
|
||||||||||||||||
| Solvent & Solubility |
In Vitro:
DMSO : ≥ 100 mg/mL (195.81 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) H2O : < 0.1 mg/mL (insoluble) *"≥" means soluble, but saturation unknown. Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles. Select the appropriate dissolution method based on your experimental animal and administration route.
For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
|
||||||||||||||||
| Purity & Documentation |
Purity: 98.0% |
||||||||||||||||
| References |
|

